Patrick F Fogarty

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Penn Comprehensive Hemophilia and Thrombosis Program, Philadelphia, PA
Hematologist, Penn Presbyternian Medical Center
Medical Director, Penn Blood Disorders Clinic, Division of Hematology/Oncology
Hematologist, Children's Hopsital of Philadelphia
Department: Medicine

Contact information
Division of Hematology/Oncology
Penn Blood Disorders Center
3rd Floor Dulles Building
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-6555
Fax: 215-615-6599
University of Pennsylvania, 1992.
M.D. (Medicine)
Jefferson Medical College, 1996.
Permanent link

Description of Itmat Expertise

von Willebrand disease

Selected Publications

Tarantino, M. D., Fogarty, P. F., Shah, P., Brainsky, A.: Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag. Platelets 26(1): 93-6, 2015.

Li, R., Panckeri, K. A., Fogarty, P. F., Diamond, S. L.: Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition. Haemophilia 21(2): 266-74, 2015.

Fogarty, P. F., Mancuso, M. E., Kasthuri, R., Bidlingmaier, C., Chitlur, M., Gomez, K., Holme, P. A., James, P., Kruse-Jarres, R., Mahlangu, J., Mingot-Castellano, M. E., Soni, A.: Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey. Haemophilia 2015.

Van Laar ES, Warren C, Desai J, Fogarty PF: Knowledge Gaps in the Management of Hemophilia among Hematologists/Oncologists. Program and abstracts of the American Society of Hematology 54th Annual Meeting (San Francisco, CA). Poster Presentation, Abstract 4831. December 2014.

Sood S, Ragni M, Kessler C, Manco-Johnson M, Quon D, Leissinger C, Gill J, Fogarty PF, Kouides P, von Drygalski A, Neff A, Kemptom C, Escobar M, Key N, Eyster E, Konkle B: A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population. Blood (supplement); Presented at the 56th American Society of Hematology Annual Meeting and Exposition, San Francisco, CA. Abstract 2836, Poster Presentation. November 2014.

Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL: Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. Biomedical Engineering Society Annual Meeting. San Antonio, TX. Poster Presentation. October 2014.

Schafer, K., Munn J., Thukral, N., Tom, A., Potts, J., Krishnan, S., Brennan, A., Pierce, G.F., McAlister, S., Shapiro, A.D., Fogarty, P.F., Quon, D.V.: Dosing Routines and Bleeding Rates Before and Following Treatment With rFVIIIFc in the A-LONG Clinical Study. Haemophilia (National Hemophilia Foundation Annual Meeting, Washington, D.C. Poster Presentation) September 2014.

Van Laar ES, Warren C, Desai J , Frick N, Fogarty PF: Global Assessment of Knowledge and Practices in the Diagnosis, Classification, and Management of Hemophilia among Pediatric Providers. Haemophilia; National Hemophilia Foundation 66th Annual Meeting (Washington, DC). Poster Presentation. Abstract 0029 September 2014.

Fogarty, Patrick.: "Maintaining a Good Relationship with Your Hemophilia Treatment Center" (Patient Education Video, Department of Continuing Medical Education, Keck School of Medicine at the University of Southern California). YouTube May 2014.

Fogarty PF, Powell J, Kruse-Jarres R, Lin J, Mahlangu J, Perry D, McRae S, Potts J, Li S, Brennan A, Pierce G: Analysis of baseline characteristics and 5-day dosing interval with rFVIIIFc in the phase 3 A-LONG study. 2014 Symposium of the Thrombosis & Hemostasis Summit of North America (THSNA), Chicago, IL. Poster presentation. April 2014.

back to top
Last updated: 11/04/2014
The Trustees of the University of Pennsylvania